Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
4.180
0.00 (0.00%)
At close: Dec 5, 2025, 4:00 PM EST
4.190
+0.010 (0.24%)
After-hours: Dec 5, 2025, 5:41 PM EST
Tvardi Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Selling, General & Admin | 8.84 | 4.46 | 2.8 | 2.73 |
| Research & Development | 21.12 | 23.65 | 15.87 | 18.47 |
| Operating Expenses | 29.96 | 28.11 | 18.67 | 21.19 |
| Operating Income | -29.96 | -28.11 | -18.67 | -21.19 |
| Interest Expense | - | - | - | -0 |
| Interest & Investment Income | 1.2 | 0.75 | 1.32 | 0.65 |
| Other Non Operating Income (Expenses) | 5.12 | -2.04 | - | - |
| Pretax Income | -23.65 | -29.4 | -17.35 | -20.54 |
| Net Income | -23.65 | -29.4 | -17.35 | -20.54 |
| Net Income to Common | -23.65 | -29.4 | -17.35 | -20.54 |
| Shares Outstanding (Basic) | 10 | 6 | 6 | 6 |
| Shares Outstanding (Diluted) | 10 | 6 | 6 | 6 |
| Shares Change (YoY) | 170.52% | 0.31% | 0.09% | - |
| EPS (Basic) | -2.48 | -4.59 | -2.72 | -3.22 |
| EPS (Diluted) | -3.23 | -4.59 | -2.72 | -3.22 |
| Free Cash Flow | -22.65 | -18.31 | -21.04 | -17.92 |
| Free Cash Flow Per Share | -2.38 | -2.86 | -3.30 | -2.81 |
| EBITDA | -29.87 | -28.01 | -18.57 | -21.11 |
| D&A For EBITDA | 0.1 | 0.1 | 0.1 | 0.09 |
| EBIT | -29.96 | -28.11 | -18.67 | -21.19 |
Source: S&P Capital IQ. Standard template.
Financial Sources.